item1.txt
Accrued legal costs as of April 30, 2018 and July 31, 2017 include $3,377,000 and $4,120,000, respectively, related to estimated costs associated with certain TeleCommunication Systems, Inc. ("TCS") intellectual property matters.
Amortization expense for the three months ended April 30, 2018 and 2017 was $5,269,000 and $5,468,000, respectively.
The sales value of this equipment was approximately $288,000.
As of July 31, 2017, the present value of the estimated facility exit costs was $1,941,000.
To date, we have incurred an immaterial amount of severance and retention costs related to our shift in strategy.
All intersegment sales are eliminated in consolidation and are excluded from the tables above.
We estimated sublease income based on (i) the terms of a fully executed sublease agreement that expired on October 31, 2015, and (ii) our assessment of future uncertainties relating to the commercial real estate market.
To qualify, we must have at least some withholding obligation.
The proceeds of these borrowings were primarily used to finance our acquisition of TCS, including the repayment of certain existing indebtedness of TCS.


item2.txt
As discussed above, our operating income for the third quarter reflects the benefit of shipments of satellite earth station equipment to the U.S. Navy that were previously expected to occur in our fourth quarter of fiscal 2018.
Based on the strength of our third quarter performance, an assessment of timing associated with our current backlog and updated mix assumptions for the remainder of fiscal 2018, we now expect consolidated operating income for the third quarter of fiscal 2018 to be the peak quarter for the fiscal year.
Net Sales.
Overall, we expect fiscal 2018 operating income in our Commercial Solutions segment, in dollars and as a percentage of related segment net sales, to increase as compared to fiscal 2017.
Sales cycles for cyber training software solutions are generally long and timing of related awards is difficult to predict.
Our Government Solutions segment represented 39.2% of consolidated net sales for the three months ended April 30, 2018, as compared to 37.9% for the three months ended April 30, 2017.
Our actual cash borrowing rate (which excludes the amortization of deferred financing costs) currently approximates 4.3%.
Our book-to-bill ratio (a measure defined as bookings divided by net sales) for the nine months ended April 30, 2018 was 1.40.
During the three months ended April 30, 2018 and 2017, customers reimbursed us $5.0 million and $5.9 million, respectively, which is not reflected in the reported research and development expenses, but is included in consolidated net sales with the related costs included in cost of sales.
In performing the quantitative assessment, we estimated the fair value of each of our reporting units using a combination of the income and market approaches.
During the nine months ended April 30, 2018 and 2017, customers reimbursed us $13.2 million and $21.9 million, respectively, which is not reflected in the reported research and development expenses, but is included in consolidated net sales with the related costs included in cost of sales.
Gross profit, as a percentage of consolidated net sales, was 42.2% for the three months ended April 30, 2018 as compared to 41.1% for the three months ended April 30, 2017.
We believe HEIGHTS is a revolutionary technology that is designed to deliver the highest Internet Protocol bits per Hertz in its class, as well as robust reliability.
We have historically met both our short-term and long-term cash requirements with funds provided by a combination of cash and cash equivalent balances, cash generated from operating activities and cash generated from financing transactions.
The increase during the most recent fiscal quarter in our Commercial Solutions segmentâ€™s operating income, in dollars and as a percentage of related segment net sales, was primarily due to higher net sales, overall favorable product mix changes and the benefit of cost reduction actions previously initiated, as discussed above.
Non-GAAP financial measures should be considered in addition to, and not as a substitute for or superior to, financial measures determined in accordance with GAAP.
Research and development expenses were $40.0 million and $40.4 million for the nine months ended April 30, 2018 and 2017, respectively, representing a decrease of $0.4 million.
Market conditions remain favorable and we expect that aggregate net sales of these solutions in fiscal 2018 will be higher than in fiscal 2017.
We allocate revenue to each separate unit of accounting in a multi-element arrangement based on the relative fair value of each element, using vendor-specific objective evidence ("VSOE") of their fair values, if available.


item3.txt



item4.txt
Item 6.


part2.txt
Item 1A.


